Rare diseases
Investigational molecules
Locations
Salvador-Allende-Strasse 1-8, Koepenick, 12559 Berlin, Germany
DRK Kliniken Berlin in Berlin, Germany specialises in clinical trials of conditions such as Colitis ulcerative, Pulmonary arterial hypertension, Crohn's disease, Colorectal cancer metastatic, and other specialisations. This site conducts important research.
At DRK Kliniken Berlin, clinical research in cardiovascular medicine focuses on reducing major heart and vascular events in people at elevated risk. The studies are designed to assess whether new treatments can better prevent serious outcomes such as heart attack, stroke, and other atherosclerotic cardiovascular disease complications.
These trials reflect a strong interest in finding more effective ways to prevent serious cardiovascular events and improve outcomes for people with obesity-related or heart-disease-related risk factors.
The site also supports research in oncology, with a particular focus on breast cancer and metastatic colorectal cancer. The studies are exploring whether newer treatment approaches can improve cancer control and help prevent recurrence in patients with early-stage or advanced disease.
This research highlights the role of Brustzentrum in advancing cancer care through trials that compare new therapies with established treatment standards.
Clinical trials in nutritional and metabolic diseases at this Berlin site are centered on obesity and related health risks. The research is examining whether new therapies can support better weight-related disease management while also lowering the chance of downstream cardiovascular complications.
These studies show a broad interest in conditions where metabolism, weight, and heart health overlap, with the goal of improving everyday care for patients at risk.
Clinical trials currently enrolling participants at this site.
GermanyLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
GermanyA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
GermanyStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
GermanyA Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer
GermanyStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
GermanyStudy on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
GermanyA Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety
GermanyObrixtamig, Carboplatin, and Etoposide for First-Line Treatment of Advanced Extrapulmonary Neuroendocrine Carcinoma in DLL3-Positive Patients
GermanyA Study Comparing PF-08634404 and a Drug Combination with Chemotherapy in Adults with Metastatic Colorectal Cancer
GermanyStudy of icotrokinra for adults with moderately to severely active Crohn's disease
GermanyStudy of Trastuzumab Deruxtecan and Pertuzumab for Patients with HER2-Positive Metastatic Breast Cancer Who Have Not Received Prior Treatment
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
